Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| CDK14 |
|
|
| CDK15 |
|
|
| CDK16 |
|
|
| CDK17 |
|
|
| CDK18 |
|
|
Selectivity
Potency Cellular
In Vitro
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.3390/ijms232314834
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.3390/ijms232314834
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.3390/ijms232314834
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.3390/ijms232314834
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.3390/ijms232314834
Negative Control Compounds
Notes: The negative control compound 314 displayed a EC50 value of 4165 nM against CDK16, determined by NanoBRETTM assay, and no stabilization against 105 kinases screened in our in-house DSF-Panel.
Chemical Information
| Molecular Formula | C24H31N7O4 |
| SMILEs | CC(C)(C)OC(=O)Nc1ccc(CNc2nccc(Nc3cc(C(=O)OC(C)(C)C)[nH]n3)n2)cc1 |
| InChI | InChI=1S/C24H31N7O4/c1-23(2,3)34-20(32)17-13-19(31-30-17)28-18-11-12-25-21(29-18)26-14-15-7-9-16(10-8-15)27-22(33)35-24(4,5)6/h7-13H,14H2,1-6H3,(H,27,33)(H3,25,26,28,29,30,31) |
| Molecular weight | 481.24 Da |
| AlogP | 0.0 |
| HBond acceptors | 11 |
| HBond donors | 4 |
| Atoms | 66 |